Non-small-cell-Lung-Cancer
Non-small-cell-Lung-Cancer
Latest Posts
-
Chemotherapy and pembrolizumab combination significantly improves outcomes in advanced non-small-cell lung cancer
The addition of PD-1 antibody pembrolizumab to standard first-line chemotherapy for treatment-naïve advanced non-small-cell lung cancer significantly improves response rates and progression-free survival, researchers reported at the ESMO 2016 Congress in Copenhagen today. Pembrolizumab is a class…
You must be logged in to post a comment.